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ABSTRACT 
 
Three-dimensional fibrous scaffolds made of a three-arm star poly(ε-caprolactone) (*PCL) were developed by 
employing a novel computer-aided wet-spinning apparatus   to precisely control the deposition pattern of an extruded 
polymeric solution as a filament into a coagulation bath. *PCL and *PCL/hydroxyapatite (HA) composite scaffolds 
composed by fibres with a porous morphology both in the outer surface and in the cross-section were successfully 
produced with a layer-by-layer approach achieving good reproducibility of the internal architecture and external shape. 
Changes in processing parameters allowed fabricating scaffolds with different architectural parameters in terms of 
average pore size in the XY axes (from 190 to 297 µm) and in the Z axis (from 54 to 126 µm), and porosity (in the 
range 20% to 60%). Mechanical characterization showed that processing conditions variation and HA loading 
influenced scaffold compressive properties. Cell culture experiments carried out by using a murine preosteoblast cell 
line showed good cell response in terms of proliferation and osteoblastic differentiation. The obtained results suggest 
the suitability of the proposed technique for the production of customized polymeric scaffolds for bone tissue 
engineering applications. 
 
 
INTRODUCTION 
 
The most common approach in the field of tissue engineering (TE) involves the employment of a three-dimensional 
(3D) matrix of synthetic or natural origin (commonly referred to as scaffold), often combined with cells and/or 
bioactive agents, that serves as a temporary platform for tissue regeneration at the affected site until the normal 
physiological functions are restored 1, 2. A scaffold should be biocompatible, biodegradable (ideally, the degradation 
 rate should match the rate of formation of the new tissue) and should support cell activity while the new extracellular 
matrix (ECM) is formed 3. In addition, a complex scaffold structure with proper porosity, pore size, pore distribution 
and external shape is a key requirement for a successful regeneration process 4. 
In order to process materials with different physical-chemical and processing properties as scaffolds with a porous 
architecture, several fabrication techniques (e.g. freeze drying, solvent casting combined with particulate leaching, 
phase inversion techniques, fibre bonding and electrospinning) have been investigated in the last two decades5. 
However, most of them present major drawbacks, including poor control over pore size, distribution and 
interconnection as well as external scaffold shape and size 6. Additive manufacturing (AM) techniques, also called solid 
freeform fabrication techniques, represent a promising alternative due to the possibility of producing scaffolds with 
tailored morphology and mechanical properties. Different AM techniques based on layer upon layer fabrication of 
scaffolds from 3D model data, such as: fused deposition modeling, stereolithography, selective laser sintering and 3D 
printing7, have been investigated in the past years for the development of complex 3D structures for TE applications. 
Wet-spinning is a non-solvent induced phase inversion technique, based on an immersion-precipitation process, 
originally developed for the production of continuous polymeric fibres for diverse industrial applications 8. Thanks to 
the possibility of processing a wide range of natural and synthetic polymers, different fabrication procedures based on 
wet-spinning fibre production were recently proposed for the preparation of TE scaffolds. Indeed, a number of studies 
published over the last years have shown the possibility to produce scaffolds composed by wet-spun fibres made of 
chitosan 9, 10, starch-based materials 11-15 and three-arm star poly(ε-caprolactone) (*PCL) 16, 17, through either a physical 
bonding of prefabricated fibres or a continuous, randomly-oriented deposition of the solidifying wet-spun filament in 
the coagulation bath. Although the obtained microfibrous scaffolds possessed an interconnected porous structure 
generally providing good in vitro cell adhesion and proliferation with penetration of cells into the inner part of the 
scaffold, the proposed techniques suffer from lack of control over pore architecture as well as over scaffold external 
shape, which is limited to simple geometries. Moreover, they require a dedicated operator to perform the whole fibre 
collection process by a manual motion of the collection system and/or to carry out the post-processing fibre bonding 
step. In order to overcome these limitations, an AM technique based on wet-spinning of polymeric solutions was 
recently applied for the layer-by-layer fabrication of 3D poly(ε-caprolactone) (PCL) scaffolds achieving good control 
over internal architecture and external shape as well as good degree of automation 18. 
Star polymers consist of linear polymer chains attached to a small central moiety. Due to their small size, spherical 
structure and limited interaction between molecules, they have different properties compared to the linear polymers 
with equivalent molecular weight, such as lower crystallinity as well as lower melting and solution viscosity, resulting 
in different processing and degradation properties19-22. *PCL, consisting of three linear PCL chains with approximately 
the same molecular weight attached to a central aluminium core 23, 24, was recently used to form electrospun and wet-
spun non-woven TE meshes that showed promising results when tested in cell culture experiments using preosteoblast 
cells 17, 25.  
Hydroxyapatite (HA), a synthetic osteoconductive ceramic with a chemical composition resembling that of bone 
apatite, has been extensively studied for bone TE applications often in combination with polymeric materials to enhance 
its toughness 26, 27. In addition, the incorporation of HA particles into polymer matrices has been shown to improve the 
osteoconductivity and mechanical properties of polymeric scaffolds and to create a pH buffer against the acidic 
degradation products of biodegradable polyesters 28-30. 
The aim of the present study was to develop 3D *PCL and *PCL/HA composite wet-spun scaffolds with predefined 
internal microstructure and external shape by employing the computer-aided wet-spinning technique previously 
 employed for the layered manufacturing of PCL scaffolds 18. A novel wet-spinning apparatus allowing enhanced 
computer-control over fabrication parameters was developed by modifying a commercial rapid prototyping system. The 
influence of different processing parameters, i.e. polymer concentration (C*PCL), deposition velocity (Vdep) and solution 
feed rate (F), on scaffold architecture and porosity was evaluated by means of scanning electron microscopy (SEM). 
Moreover, the developed scaffolds were characterized for their compressive mechanical behaviour by uniaxial static 
test, thermal properties by thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC) and in vitro 
cytocompatibility by using the MC3T3-E1 murine preosteoblast cell line. 
 
MATERIALS AND METHODS 
 
Materials 
Three-arm star branched poly(ε-caprolactone) (*PCL, Mw = 189,000 g/mol), was provided by Michigan Biotechnology 
Institute (Lansing, MI, USA), hydroxyapatite nanoparticles (HA, size < 200 nm) were bought from Sigma-Aldrich 
(Milan, Italy). Acetone and ethanol were purchased from Sigma-Aldrich (Milan, Italy) and used as received. 
 
THROUGH OUT THE EXPEIMENTAL ONLY,  
PLEASE CHANGE ALL “hours and minutes” TO “h” and “min” RESPECTIVELY 
 
Computer-aided wet-spinning apparatus 
Scaffolds were produced using an in-house modified subtractive Rapid Prototyping system (MDX-40A, ROLAND DG 
Mid Europe Srl, Ancona, Italy). The milling head unit was replaced with a syringe pump system (NE-1000, New Era 
Pump Systems Inc., Wantagh, NY, USA) to enable the deposition of polymeric solutions with a controlled 3D pattern 
(Figure 1a). The lay-down pattern for scaffold production was calculated using an algorithm developed in Matlab 
software (The Mathworks, Inc.) and uploaded into the equipment through the software Vpanel for MDX-40A.  
 
Solutions preparation 
 
*PCL pellets were dissolved in acetone at 35°C for 3 h under gentle stirring to obtain homogeneous solutions at the 
desired concentrations (15 to 30% w/v). For the production of *PCL/HA composite scaffolds, HA nanoparticles were 
added to the polymeric solution and left under vigorous stirring at 35°C for 1 h until a homogeneous dispersion of the 
nanoparticles was achieved. On the basis of the results achieved in a previous study17, the weight ratio between HA and 
*PCL in the solution was chosen to be 25%. 
 
Scaffold production and design  
 
The prepared solution was loaded into a 5 ml syringe, fitted with a blunt tip stainless steel needle (inner diameter = 0.34 
mm, length = 15 mm), and placed into the syringe pump. The 3D scaffolds with predefined architectures were 
fabricated with a layer-by-layer process, using the previously described computer-aided wet-spinning apparatus, by 
extruding the solution directly into a glass beaker containing ethanol (Figure 1a).  The initial distance between the tip of 
the needle and the bottom of the beaker (Z0) was 1 mm. A deposition trajectory aimed at the production of scaffolds 
with 0-90º lay-down pattern, distance between fibre axis (d2) of 500 µm and layer thickness (d3) of 200 µm was 
employed (Figure 1b). The effect of different processing parameters such as Vdep C*PCL and F on fibre collection and 
 morphology was evaluated (Table 1). Samples of cylindrical geometry with a diameter of around 15 mm and composed 
of 25 layers for mechanical characterization or 10 layers for biological investigations were produced. After fabrication, 
the scaffolds were removed from the coagulation bath and kept under a fume hood overnight. Residual solvents were 
removed by keeping the scaffolds in a vacuum chamber for 48 h. 
 
Morphological analysis 
The scaffold morphology was assessed using scanning electron microscopy (SEM, JEOL LSM 5600LV, Tokio, Japan) 
under backscattered electron imaging. SEM micrographs were acquired from the top view and the cross-section 
(obtained by fracture in liquid nitrogen) of the scaffolds at different magnifications. Structural parameters, such as 
average fibre diameter (d1) and pore size, were determined by means of ImageJ 1.43u software (National Institutes of 
Health, Bethesda, MD, USA) on SEM micrographs with a 35X magnification. Data were calculated over 20 
measurements per scaffold. 
The scaffold porosity was evaluated using the theoretical approach proposed by Landers et al 31:  
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where P is the porosity of the scaffold, d1 is the fibre diameter, d2 the distance between fibre axis and d3 layer thickness. 
The microporosity of the single fibre was not considered in this calculation. 
 
Thermal properties 
 
Thermal properties of the raw materials and scaffolds were evaluated by means of thermogravimetric analysis (TGA) 
and differential scanning calorimetry (DSC). TGA was performed using a TGA Q500 instrument (TA Instruments, 
Milan, Italy) in the temperature range 30–600ºC, at a heating rate of 20ºC·min-1 and under a nitrogen flow of 60 
mL·min-1. The degradation temperature (Td) was evaluated as the temperature corresponding to a percentage weight 
loss of 5%. 
DSC analysis was performed in the range -100 to 100ºC, at a heating and cooling rate of 10ºC·min-1 and under a 
nitrogen flow rate of 80 mL·min-1, using a Mettler DSC-822 (Mettler Toledo, Milan, Italy). By considering the first and 
second heating cycle in the thermograms, glass transition temperature (Tg) was evaluated by analysing the inflection 
point, while melting temperature (Tm) and crystallinity by analysing the endothermic peak. 
 
Mechanical characterization 
 
Compression characterization was performed at room temperature and ambient humidity using an INSTRON 5564 
(Instron Corporation, MA, USA) equipped with a 2kN load cell. Five samples of each scaffold type with a diameter (d) 
of 13.2±0.5 and height (h0) of 3.9±0.2 mm were tested.  The samples were compressed by employing two parallel plates 
at a strain rate of 0.5 mm·min-1 and up to a strain value of 0.5 mm·mm-1. The stress was defined as the measured force 
divided by the total area of the apparent cross-section of the scaffold, whilst the strain was evaluated as the ratio 
between the scaffold height variation and its initial height. 
  
Biological evaluation  
 
Scaffold sterilization 
 
Scaffolds were placed in a 24-well plate, exposed to UV light for 2 h on each side and disinfected with 70% 
ethanol/water solution for 3 h. After ethanol removal, scaffolds were extensively washed with Dulbecco’s Phosphate 
Buffer Saline (DPBS, pH 7.4) containing 1% penicillin/streptomycin and were then left overnight at 37 °C in  5% CO2. 
 
Cell culturing and cell seeding 
 
Mouse calvaria-derived preosteoblastic cells (MC3T3-E1) subclone 4 were obtained from the American Type 
Culture Collection (ATCC CRL-2593) (LGC Standards, Milan, Italy) and cultured as monolayers in Alpha 
Minimum Essential Medium (α-MEM, Sigma-Aldrich, Milan, Italy), containing ribonucleosides, 
deoxyribonucleosides and sodium bicarbonate, supplemented with L-glutamine (2 mM), fetal bovine serum 
(10%), penicillin:streptomycin solution (100 U/ml:100µg/ml) (1%) and antimycotic agent (Invivogen, Milan, 
Italy). The cultures were mantained at 37 °C in 5% CO2. 
MC3T3 cells were seeded at an appropriate density (0.5 x 104) onto the scaffolds as previously described 18. Twenty-
four h after seeding, scaffolds were incubated with osteogenic medium by supplementing the α-MEM with ascorbic 
acid (0.3 mM) 32 and β-glycerophosphate (10 mM) 33, in order to induce and promote the osteoblastic phenotype 
expression of MC3T3-E1. The medium was replaced every 48 h. 
 
Cell viability and cell proliferation 
 
Cell viability and proliferation were measured by using the cell proliferation reagent WST-1 (Roche Diagnostics, 
Monza, Italy) on days 7, 14, 21 and 28, after cell seeding, as previously described 18. Briefly, the assay was performed 
by incubating cell-seeded scaffolds with the reagent for 4 h. Measurements of formazan dye absorbance were carried 
out at 450 nm. 
 
 
Quantification of collagen production 
 
Assessment of collagen production by MC3T3-E1 cultured on *PCL based scaffolds, as an indicator of osteoblastic 
marker, was carried out at day 7 and 28. At each time point the medium was removed and the samples were washed 
twice with DPBS. Scaffolds were then incubated with Direct Red 80 dye (Sigma-Aldrich, Milan, Italy) dissolved in 
picric acid (0.1%), for 1 h at room temperature. After incubation the dye solution was removed and the samples were 
washed three times with 10 mM HCl to remove the excess dye. The elution of the bound stain was performed with 0.1 
N NaOH for 30 min at 37°C. Supernatants were plated in a 96-well plate and the absorbance was read at 540 nm. 
Scaffolds without cells were treated with the same protocol and considered as blank. 
The photometric quantification of the collagen was obtained by means of a calibration curve prepared with collagen 
type I, derived from calf’s skin (Sigma-Aldrich, Milan, Italy). Briefly, known concentrations of collagen in acetic acid 
(0.1 M) were filmed and dried on glass slides by a solvent casting technique in order to obtain a thin film. Films were 
then fixed and treated as the samples 34. 
  
Alkaline phosphatase (ALP) activity 
 
Alkaline phosphatase (ALP) activity was determined in cultured MC3T3-E1-*PCL constructs on days 7, 14, 21, and 28, 
as previously described 18. Briefly, scaffolds were washed three times with DPBS, treated with lysis buffer followed by 
freezing-thawing cycles. Subsequently the supernatant was taken from the samples, added into p-nitrophenyl phosphate 
substrate (Sigma-Aldrich, Milan, Italy) and the reaction was left to take place at 37°C for 30 min. The absorbance was 
measured at 405 nm using a spectrophotometer. The molar concentration of ALP was normalized with the total protein 
content of each sample, which was measured using the Bradford protein assay (Pierce, Rockford, IL, USA). The results 
for ALP activity assay were reported as nanomoles (nmol) of converted substrate per minute and mg of total proteins. 
 
Cell morphology investigation by confocal laser scanning microscopy (CLSM) 
 
The morphology of MC3T3-E1 cells grown on *PCL constructs and their 3D organization were investigated on day 7, 
14, 21, and 28 by means of a Nikon Eclipse TE2000 (Nikon Instruments, Florence, Italy) inverted microscope equipped 
with an EZ-C1 confocal laser setup. Cells were fixed with 3.8% p-formaldehyde for 30 min and processed as previously 
described 18. Captured images were further processed with The GIMP (GNU Free Software Foundation) image 
manipulation software and merged with Nikon ACT-2U software. 
 
Statistical evaluation  
 
Quantitative data were presented as mean ± standard deviation (SD). Data sets were screened by one-way ANOVA and 
a Tukey test was used for post hoc analysis; significance was defined at p < 0.05. 
 
RESULTS AND DISCUSSION 
 
*PCL and *PCL/HA composite scaffolds were prepared by a new computer-aided wet-spinning apparatus that allows 
for enhanced control of the deposition process on the three XYZ axes (Figure 1c). The processing conditions for the 
obtainment of 3D structures with a controlled internal network of pores and a predesigned external shape were 
investigated. The developed scaffolds were characterized for their morphological, thermal and mechanical properties as 
well as for their cytocompatibility using the MC3T3-E1 murine preosteoblast cell line. 
 
Additive Manufacturing (AM) of scaffolds  
 
The AM process involved the extrusion of a polymeric solution directly into a coagulation bath and the synchronized 
motion of the needle and of the construction platform for the deposition of the solidifying solution filament with a 
predefined pattern. The solvent/non-solvent (acetone/ethanol) system optimized in previous work on *PCL wet-
spinning 16, 17 was employed. Parameters, such as lay-down pattern, needle inner diameter, needle tip-to-beaker bottom 
initial distance (Z0), Z inter-layer needle translation distance (d3) and distance between XY deposition lines (d2), were 
chosen on the base of preliminary investigations and kept constant during the study of the influence of C*PCL, Vdep and F 
on scaffold morphology.  
SEM image analysis showed good reproducibility of the internal architecture of the scaffolds in terms of fibre 
morphology and size, fibre alignment and layered structure. The scaffolds were composed of overlapping layers of 
oriented *PCL fibres. Individual fibres had a highly porous morphology both at the outer surface and in cross-section 
 (Figures 2 and 3). The fibre porosity was a consequence of the solution filament solidification mechanism based on the 
solvent-non-solvent counter-diffusion in the coagulation bath. This induced a phase separation into a polymer-rich 
matrix surrounding polymer-lean droplets that formed the pores after complete solidification and solvent removal 17.  
The computer-aided wet-spinning technique offers all of the typical advantages of the melt-extrusion based AM 
technique (e.g. Fused Deposition Modelling )such as, customized pore size, pore geometry and 3D external shape 18. In 
comparison to dense strands fabricated by FDM, the porous morphology of the single fibres constituting the wet-spun 
scaffolds can present some advantages in influencing the biodegradation rate, the mass transfer associated with drug 
release and cell metabolic activities that regulate cell adhesion and proliferation 4, 18. In addition, the process can 
accommodate loading the scaffolds with bioactive agents that are sensitive to high temperatures but have good stability 
in the solvents employed (i.e. acetone and ethanol). The major concerns of the technique are the need of a post-
processing step to eliminate residual organic solvents from the polymeric matrix, and the lower mechanical 
performance in comparison to that achieved by FDM due to the spongy morphology of the single fibre 18. In addition, 
the relatively large pore size and fiber diameter of the obtained scaffolds (Table 1) will not allow all the advantages of 
nanofibrous electrospun assemblies, that greatly favour cell adhesion and provide a 3D microenvironment ideal for cell-
cell interaction35-41. Future studies will combine the 3D microstructure by computer-aided wet-spinning, conferring the 
anatomical shape and mechanical stability to the scaffold, and a nanosized fibrous structure by electrospinning which 
can enhance the biological performance of the scaffold 42. 
 
Effect of polymer concentration (C*PCL) 
The influence of C*PCL on scaffold morphology was investigated in the range of 15-30% w/v while keeping constant 
Vdep (240 mm·min-1) and F (1 ml·h-1). When C*PCL was lower than 20% w/v, the filament solidification process was too 
slow to obtain a fibrous structure and widespread fibre-fibre fusion was observed. An increase in C*PCL resulted in 
enhanced fibre morphology and thus in a well-defined 3D fibrous structure (Figure 2a). Analysing the top view SEM 
micrographs of fibre collections obtained for C*PCL from 20 to 30% w/v, a more uniform fibre morphology and better 
fibre alignment was evident for scaffolds obtained at higher concentrations. In particular, fibres look flattened at the 
fibre-fibre intersection points for lower concentrations, and the bonding area in the conjunction region decreased with 
the increasing of C*PCL. As shown in table 1, this caused a statistically significant increase of pore size along Z axis by 
increasing C*PCL leading to an increase of scaffold porosity. However, non-significant differences in d1 and d,(d2?) and 
as consequence, in XY pores, were observed. In addition, as shown by high magnification micrographs (Figure 3), the 
increase in C*PCL led to a more porous morphology of fibre outer surface. The best results, in terms of fibre morphology 
and alignment as well as scaffold porosity, was achieved for C*PCL of 30% w/v, making this concentration ideal for 
further processing parameters studies.  
The morphology of porous structures obtained through phase inversion by non-solvent addition is strongly related to 
solvent/non-solvent demixing kinetics 43. In the case of slow demixing, a uniform pore structure, in terms of size, 
geometry and distribution, is usually achieved. Inversely, a fast demixing originates a dense “skin” on the surface 
interfacing with the coagulant fluid and an irregular pore distribution underneath, typically presenting finger-like pores. 
A number of papers suggested that when polymer concentration is increased a slower solvent/non-solvent mixing takes 
place 44-47. The results achieved in the present study are consistent with those of previous research suggesting that an 
increase of polymer concentration in a certain range leads to a more uniform wet-spun fibre porosity likely because of a 
slower demixing 48. In addition, the diminished effect of fibre flattening at the contact points with increasing C*PCL can 
be also explained with the slower demixing and/or the increased solution viscosity. 
  
Effect of deposition velocity (Vdep) and solution feed rate (F) 
 
The effect of Vdep on scaffold morphology was evaluated in the range 180 to 300 mm·min-1 at the optimized C*PCL (30% 
w/v) and constant F (1 ml·h-1). When Vdep was below 200 mm·min-1 the formation of a porous structure was 
compromized due to fibre-fibre fusion within the same layer, while in the case of Vdep above 280 mm·min-1 the 
adhesion between adjacent layers was limited, compromising the structural integrity of the scaffold. However, when 
Vdep was in the range 200 to 280 mm·min-1 a 3D fully interconnected porous structure, characterized by a good degree 
of fibre alignment, was obtained (Figure 2b). By increasing Vdep in this range, d1 decreased significantly and, 
accordingly, XY pores size and scaffold porosity increased (table 1). However, scaffolds obtained at the high Vdep 
showed in some cases delamination between adjacent layers, likely because of the limited merging at the fibre-fibre 
contact points. The influence of F was investigated in the range 0.6 to 1.2 ml·h-1 keeping constant the optimized 
conditions of C*PCL and Vdep (30% w/v and 240 mm·min-1, respectively). Delamination of the layered structure was 
observed for low values of F, while fibre-fibre fusion was too marked compromising scaffold porosity along Z axis 
when 1.2 ml·h-1 was applied. However, when F was in the range 0.8 – 1.1 ml·h-1, good fibre morphology and alignment 
were achieved (Figure 2c). By increasing F in this range, fibres looked more flattened at the contact points, and d1 
increased significantly while scaffold porosity decreased (table 1). Considering the results obtained from the above 
presented investigations, the optimized processing conditions for *PCL scaffold fabrication were C*PCL = 30% w/v, Vdep 
= 240 mm·min-1 and F = 1.0 ml·h-1.  
A proper balance between F and Vdep is necessary for the deposition of a straight fibre with cylindrical morphology, 
which is needed for its uniform stretching. This balance is needed as well for partial fusion at the fibre-fibre contact 
points, which is essential for a cohesive 3D architecture with good integrity and mechanical behaviour. As shown in the 
current study, by varying either Vdep or F in a certain range it is possible to optimize fibre morphology and to tune fibre 
diameter, pore size and overall scaffold porosity. However, if Vdep is too high or F too low, the stretching force acting 
on the solidifying filament can cause its breaking or can limit fibre-fibre contact area where interlayer adhesion takes 
place. In addition, for a given distance between the needle tip and the previous layer (depending on Z0 and d3), 
inappropriate Vdep/F combinations can result in a low velocity of the solution filament that solidifies before settling onto 
the previously deposited layer, thus limiting the adhesion at the fibre-fibre contact points. On the contrary, if Vdep is too 
low or F too high, the filament is not solidified enough when it reaches the previous layer and a controlled fibrous 
deposition is compromized due to non-uniform fibre morphology or excessive fibre-fibre fusion. 
 
 
Effect of hydroxyapatite (HA) loading 
By applying the optimized Vdep and F (240 mm·min-1 and 1 ml·h-1, respectively), HA-loaded *PCL scaffolds (HA/*PCL 
weight ratio of 25%) were fabricated by processing solutions with different C*PCL (20 or 30% w/v). Composite scaffolds 
revealed a morphology close to that of plain *PCL scaffolds with good degree of fibre alignment (Figure 4a,b). For the 
HA-loaded *PCL scaffold, a change of C*PCL had a significant effect on the obtained d1 but not on the pore size in XY 
and Z axis (Table 1). Moreover, d1 was significantly smaller while the XY and Z pore sizes were significantly larger 
when compared to plain *PCL scaffolds. High magnification SEM micrographs showed a good dispersion of HA 
nanoparticle microaggregates both in the outer surface and in the cross-section of the fibres (Figure 4c,d). According to 
a previous study on wet-spun *PCL17, the surface and cross-section porosity of HA-loaded scaffolds was lower in 
 comparison to plain *PCL scaffolds obtained by applying the same processing conditions (Figure 4c,d vs Figure 3c,f). 
The presence of additives in the polymer solution can indeed affect the kinetics and thermodynamics of the phase-
inversion process and therefore the resulting fibre morphology 17, 49-52. The lower porosity observed may be due to a 
faster solidification and an interaction between *PCL and HA in the solution, which affects polymer solvation and 
consequently the coagulation process17. Analogously, the lower fibre size of HA-loaded scaffolds may be related to 
such an effect on solidification kinetics. 
 
Mechanical Characterization 
 
The compressive mechanical properties of the developed scaffolds were evaluated by means of a uniaxial testing 
machine (strain rate = 0.5 mm·min-1 and maximum strain = 0.5 mm·mm-1) and the effect of C*PCL in the range 20 - 30% 
w/v (Vdep = 240 mm·min-1 and F = 1.0 ml·h-1) and HA loading on mechanical parameters was investigated. The stress-
strain curves (Figure 5) showed an initial linear region followed by a plateau and a subsequent region of increasing 
slope. As discussed in previous articles investigating the mechanical behaviour of porous  scaffold structures fabricated 
by melt extrusion-based AM techniques 53, 54, the linear region is likely due to the response of the fibre-fibre contact 
points to the applied deformation, the subsequent plateau region to the collapse of the pores network and the final 
increase of the compressive stress to a further densification of the scaffold structure.  
As reported in Table 2, an increase of C*PCL in the investigated range led to a significant increase of compressive 
modulus from 1.42 ± 0.44 to 3.62 ± 0.94 MPa and maximum stress from 0.54 ± 0.08 to 0.96 ± 0.11 MPa. This can be 
explained by the more uniform fibre morphology at the contact points when higher C*PCL was employed. In addition, the 
HA-loaded scaffolds showed a significantly higher compressive modulus and strength in comparison with the *PCL 
plain scaffolds, corroborating results from previous studies investigating the effect of HA-loading on mechanical 
properties of scaffolds fabricated by melt extrusion-based 55-60 or solution extrusion-based techniques 18.  
In comparison with linear PCL scaffolds fabricated using the same AM technique 18, the developed *PCL scaffolds 
showed significantly higher mechanical properties, that may be explained by the different macromolecular structure of 
the two polymers, the higher polymer concentration employed in this study and/or the more advanced technological 
solutions that provide a better deposition resolution. However, the manufactured scaffolds still present mechanical 
properties insufficient for application in load-bearing bone tissues. Further studies should be conducted to investigate 
the enhancement of scaffold mechanical properties by increasing HA loading and/or by increasing fibre packing density 
together with decreasing fibre diameter. 
 
Thermal properties 
 
The thermal properties of optimized *PCL-based scaffolds, obtained employing the processing parameters (C*PCL = 30% 
w/v, Vdep = 240 mm·min-1 and F = 1.0 ml·h-1) that achieved the best performance in terms of morphology and 
mechanical properties, were investigated in comparison to unprocessed *PCL (Table 3). As shown by TGA 
characterization, the degradation temperature (Td) of scaffolds and unprocessed polymer was above 300° C.  The 
amount of HA actually loaded in the composite scaffolds was estimated by the analysis of the residue weight percentage 
at 550°C that was 22.92%, nearly the HA weight percentage in the polymeric solution (20% wt). DSC analysis was 
performed in order to study the effect of materials processing and HA loading on *PCL thermal properties. By 
comparing data from the first scan, fibrous-structured *PCL showed higher crystallinity and lower Tm than raw *PCL, 
while Tg values were comparable. However, second scan analysis (after sample melting to remove previous thermal 
 history) showed that the thermal properties of processed *PCL were comparable to those of raw *PCL, suggesting that 
wet-spinning didn’t cause remarkable chemical-physical changes in polymer structure. 
Crystallinity influences different properties of biodegradable polyesters such as degradation rate. Indeed, since water 
molecules and enzymes diffuse first into amorphous domains, polymer degradation rate is directly correlated to its 
crystallinity degree that changes during hydrolytic degradation 61, 62. As shown in previous studies, the solidification 
process and conditions involved in different techniques for the preparation of PCL-based constructs (e.g. compression 
moulding, solvent casting, phase inversion techniques) greatly influence polymer crystallinity 61, 63. The comparative 
DSC analysis of the current study corroborates results of other research activities finding that phase inversion-based 
material processing can significantly affect the crystallization process during polymer solidification and that a slow, 
gradual precipitation from solution generally allows the development of high levels of crystallinity 61, 64, 65. Changes in 
coagulation kinetics induced by acting on different phase inversion conditions (e.g. solvent/non-solvent system, 
polymer concentration, coagulation time and temperature, presence of additives) can thus represent an effective tool for 
varying the crystallinity, and as consequence degradation rate and mechanical properties, of wet-spun fibrous scaffolds 
made of biodegradable polyesters.  
 
 
Biological evaluation 
 
Cell viability and proliferation on scaffolds 
 
Biological investigations of the prepared *PCL scaffolds were carried out in order to evaluate cell viability and 
proliferation using the MC3T3-E1 cell line. Quantitative evaluation of cell proliferation onto scaffolds was performed 
weekly by means of the WST-1 assay. Results highlighted the ability of all investigated samples to sustain cell 
proliferation in both growing conditions (Figure 6a). At the very beginning the cell-material interactions and the cell 
seeding density played a crucial role on cell attachment and influenced the cell proliferation in the early culturing 
times66. In fact, during the first two weeks of culture a delay in cell proliferation was observed for both culture 
conditions and scaffold types. This behaviour was especially evident for MC3T3-E1 cultured on *PCL/HA constructs. 
The HA presence in the construct could positively influence the switch between proliferation and differentiation 
process32, by promoting the expression of cell osteoblastic phenotype with a decrease in cell proliferation. 25. Values of 
cell viability and proliferation were also compared to those observed for wet-spun linear PCL constructs18, which 
confirmed the good cytocompatibility as well as the slight delay in MC3T3-E1 cell proliferation when cells were grown 
in the presence of synthetic HA in the polymeric matrix. 
 
Collagen production 
 
Collagen production of preosteoblast cells, cultured on *PCL and *PCL/HA scaffolds, was measured and quantified as 
reported in Figure 6b. The 3D constructs induced MC3T3-E1 cells to produce high levels of collagen in agreement with  
previous studies using *PCL electrospun meshes25. Both types of scaffold and culturing conditions showed statistically 
significant values (p<0.001) of collagen production with a sharply increasing time-dependent trend, confirming the 
bioactivity and the suitability of the prepared supports as bone substitutes. 
 
ALP activity measurement 
 
 ALP is considered an early indicator of osteoblastic phenotype expression and its activity was measured to determine 
the MC3T3-E1 preosteoblast cell differentiation 67. 
In the first three weeks of culture, MC3T3-E1 grown on *PCL and *PCL/HA scaffolds produced comparable ALP 
levels with no visible increase during the culturing period (Figure. 6c).  Significant levels of ALP were present during 
the first week (p < 0.05).  
A considerable increase in ALP levels was observed for the samples treated with osteogenic medium. This phenomenon 
confirmed that ascorbic acid and β-glycerophosphate support phenotypic differentiation by triggering the enzyme’s 
expression33, 68. The presence of a synthetic calcium phosphate ceramic (i.e. HA), selected as a reinforcing bioactive 
agent in the *PCL constructs, did not improve the scaffolds’ osteoconductivity during the first 21 days of culture. 
Increasing values of ALP were detected at the endpoint of analysis (day 28) for all the investigated samples. In 
particular, the osteogenic medium and the synergy between the modified medium and the HA polymeric matrix that 
mimics the natural apatite composition of bones and teeth, seemed to induce MC3T3-E1 cell differentiation. This result 
is confirmed by data from the literature69,70. Moreover, this behaviour confirmed the need for the MC3T3-E1 to reach an 
adequate cell confluence on the 3D constructs combined with the production of early matrix proteins as type I collagen, 
fibronectin and transforming growth factor beta (TGF-β1), prior to the expression of high levels of ALP, an early 
marker of mature osteoblast function 32, 70, 71. 
 
Cell culture organization on scaffolds 
 
Fluorescent staining of F-actin and nuclei of cells showed preosteoblast colonization of the cultured scaffolds. At early 
stages of culture (day 7), microscopic observation showed a poor presence of adherent cells on fibre surfaces in every 
experimental condition, confirming the cell proliferation data. Moreover, cells displayed a variable shape and spreading 
consistent with early stages of cell adaptation to the material 60 (Figure 7). At days 14 and 21, the lower cell number of 
MC3T3-E1 grown on *PCL/HA constructs compared to those present on plain *PCL based scaffolds was rather 
evident. In accordance with the in vitro differentiation model32, 70, after an initial phase characterized by replication of 
undifferentiated cells, preosteoblasts started the differentiation process ceasing proliferation. At the final culture 
endpoint (day 28), MC3T3-E1 cultures in differentiating conditions exhibited polygonal morphology with a 
cytoskeleton structure resembling the osteoblast phenotype (Figure 8). Plain *PCL samples, lacking any differentiating 
stimulus, exhibited the higher level of cell viability.  
All scaffolds allowed preosteoblasts growth and colonization, revealing similar results at early stages but suggesting, at 
longer culture times, suitability for differentiation toward osteoblast phenotype under appropriated differentiation 
conditions. 
 
 
CONCLUSIONS 
 
An improved computer-assisted apparatus for wet-spinning of polymeric solutions with enhanced control over 
fabrication parameters was employed to produce highly porous 3D *PCL or *PCL/HA-based composite scaffolds. The 
fabrication process showed good reproducibility of the internal architecture and external shape as well as low 
production time. The scaffolds were composed of aligned fibres with a highly porous morphology, due to the phase 
inversion process governing solution filament solidification. A proper tuning of C*PCL, F and Vdep enabled variation of  
fibre diameter, pore size and scaffold porosity. A change in C*PCL and HA-loading enhanced the compressive 
mechanical properties. The *PCL and *PCL/HA scaffolds were fully cytocompatible and able to sustain murine 
 preosteoblast MC3T3-E1 cell adhesion, proliferation and colonization. Moreover, osteogenic markers confirmed the 
suitability of the prepared scaffolds to promote the osteoblastic differentiation process. The in vivo evaluation of these 
types of *PCL scaffolds on New Zealand rabbits is part of an ongoing research that will be published in a forthcoming 
paper.  
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 Figure 1 – a) Scheme of computer-aided wet-spinning apparatus, b) design of 3D scaffolds with a cylindrical geometry 
characterized by a 0-90° lay-down pattern, a diameter of 15 mm and either 10 or 25 overlapped layers (~ 2 and 5 mm 
thickness, respectively) and c) photograph of the produced scaffolds composed by 10 layers (left) and 25 layers (right). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 2 – Backscatter SEM micrographs of the top view and cross-section of *PCL scaffolds obtained for: a) C*PCL in 
the range 20 – 30% w/v (Vdep=240 mm·min-1 and F=1 ml·h-1); b) Vdep in the range 200 – 280 mm·min-1 (F=1 ml·h-1and 
C*PCL = 30% w/v); c) F in the range 0.9 – 1.1 ml·h-1 (Vdep=240 mm·min-1 and C*PCL = 30% w/v). 
 
 
 
 
 
 Figure 3 - SEM micrographs showing single fibre porosity: outer surface (a-c) and internal porosity (d-f). 
Fabrication parameters: Vdep = 240 mm·min-1, F=1 ml·h-1 and C*PCL from 20 to 30% w/v.  
 
 
 
 
 
Figure 4 - SEM micrographs of *PCL/HA scaffolds produced with a C*PCL of 30% w/v, F=1 ml·h-1 and 
Vdep=240mm·min-1: a) top view, b) scaffold cross-section, c) fibre external surface, d) fibre cross-section. 
 
 
 
 
 
 
 
 Figure 5 – Typical stress-strain curves obtained for scaffolds produced employing different C*PCL and loaded with HA, 
compressed at a rate of 0.5 mm·min-1 up to a strain value of 0.5 mm·mm-1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 6 - MC3T3-E1 cell cultured on *PCL and *PCL/HA based scaffolds in non-osteogenic (n.o.) and osteogenic 
(ost.) medium: a) proliferation investigated by means of WST-1 reagent, b) collagen production investigated by means 
of Direct Red 80 staining method and c) alkaline phosphatase activity. 
 
 
 
 
 
 
 
  Figure 7 - CLSM micrograph of MC3T3-E1 cells cultured on *PCL and *PCL/HA scaffolds at different end-points (7, 
14, 21 and 28 days) and growing conditions (n.o. = non-osteogenic and ost. = osteogenic) (scale bar= 100 µm). 
 
 
 
 Figure 8 - CLSM micrographs of MC3T3-E1 cells cultured on *PCL (a : non-osteogenic; b:osteogenic) and *PCL/HA 
(c : non-osteogenic; d:osteogenic) scaffolds at 28 days of culture (scale bar= 50 µm). 
 
 
 
 Table 1 – Fibres diameter, pore size and porosity of *PCL and *PCL/HA scaffolds at different processing conditions. 
Values are presented as mean ± standard deviation 
*P
C
L
 
Polymer 
concentration 
(C*PCL) [% w/v] 
Fibre 
diameter (d1) 
[µm] 
Pore size 
(X and Y axis) 
[µm] 
Pore size 
(Z axis) 
[µm] 
Porosity 
[%] 
20 246±19 225±40 68±21 (*) 36 
25 242±18 235±23 95±14 (*) 43 
30 232±4 232±22 126±12 (*) 49 
Deposition 
Velocity (Vdep)  
[mm·min-1] 
 
200 266±8 (*) 190±19 (*) 54±8 (*) 24 
240 232±4 (*) 232±22 (*) 126±12 49 
280 201±8 (*) 279±40 (*) 118±15 59 
Feed Rate (F)  
[ml·h-1] 
 
0.8 189±4 (*) 256±33 (*vs.1.0 and 1.1 ml·h-1) 
122±9 
(*vs. 0.9 and 1.1 1ml·h-1) 60 
0.9 195±3 (*) 271±31 (*vs.1.0 and 1.1 1ml·h-1) 109±9 
(*) 58 
1.0 232±4 (*) 232±22 (*) 126±12 (*vs. 0.9 and 1.1 1ml·h-1) 49 
1.1 274±8 (*) 297±38 (*) 62±12 (*) 26 
*P
C
L
/H
A
 Polymer 
concentration 
(C*PCL) [% w/v] 
Vdep = 240 mm·min-1; F = 1 ml·h-1; 
20 194±6 (*,**) 280±23 (**) 99±8 (**) 58 
30 202±2 (*,**) 275±25 (**) 89±17 (**) 54 
 
(*) parameter significantly different (p < 0.05) when compared to those of other scaffolds developed within each 
independent study of processing variable effect (C*PCL, Vdep and F), (**) parameter significantly different (p < 0.05) 
when compared to that of the analogous plain *PCL scaffold obtained applying the same processing conditions.  
 
Table 2 – Compressive modulus and maximum stress of scaffolds produced with different C*PCL 
and loaded with HA. The obtained values are reported as mean ± standard deviation (n=5). 
 
Scaffold C*PCL [% w/v] 
Compressive Modulus 
[MPa] 
Maximum Stress 
(50% strain) 
[MPa] 
*PCL 
20 1.42±0.44 (*) 0.54±0.08 (* vs 30%) 
25 2.78±0.70 (* vs 20%) 0.65±0.09 (* vs 30%) 
30 3.62±0.94 (* vs 20%) 0.96±0.11 (*) 
*PCL/HA 30 7.28±1.26 (**) 1.51±0.26 (**) 
 
(*) parameter significantly different (p < 0.05) when compared to those of other scaffolds with different C*PCL, (**) 
parameter significantly different (p < 0.05) when compared to that of the analogous plain *PCL scaffold obtained 
employing the same C*PCL (30% w/v). 
 
 
 Table 3 – Thermal properties of raw *PCL and *PCL-based scaffolds obtained by means of TGA 
and DSC. 
 
 
 1st heating 2nd heating 
 
Td 
(ºC) 
Tg  
(ºC) 
Tm  
(ºC) C% 
Tg  
(ºC) 
Tm  
(ºC) C% 
*PCL raw 311.05 -63.70 66.91 61.95 -64.37 56.08 51.41 
*PCL scaffold 317.75 -62.01 62.60 67.40 -63.52 56.33 51.85 
*PCL/HA scaffold 310.66 -60.86 63.28 66.82 -64.19 56.62 53.41 
 
 
 
